Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.26 USD | -4.16% | -7.65% | -8.39% |
May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.39% | 212M | |
+11.17% | 115B | |
+12.68% | 106B | |
-4.21% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-12.24% | 17.56B | |
-40.50% | 17.32B | |
+7.30% | 14.03B | |
+33.00% | 12.13B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- BTIG Adjusts INmune Bio's Price Target to $14 From $31, Reiterates Buy Rating